Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1475-2840
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes ; volume:14 ; number:1 ; day:6 ; month:6 ; year:2015 ; pages:1-8 ; date:12.2015
Cardiovascular diabetology ; 14, Heft 1 (6.6.2015), 1-8, 12.2015

Urheber
Xiao, Yang
Liu, Lingjiao
Xu, Aimin
Zhou, Pengcheng
Long, Zhaofeng
Tu, Yiting
Chen, Xiaoyan
Tang, Weili
Huang, Gan
Zhou, Zhiguang
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12933-015-0229-9
URN
urn:nbn:de:101:1-2021082923184852871249
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:34 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Xiao, Yang
  • Liu, Lingjiao
  • Xu, Aimin
  • Zhou, Pengcheng
  • Long, Zhaofeng
  • Tu, Yiting
  • Chen, Xiaoyan
  • Tang, Weili
  • Huang, Gan
  • Zhou, Zhiguang
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes

Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes

Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis

Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study

P01-014 – Subclinical atherosclerosis in FMF

P01-014 – Subclinical atherosclerosis in FMF

Predictors of subclinical atherosclerosis in HIV

Predictors of subclinical atherosclerosis in HIV

Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot

Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease

Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes

Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes

Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity

Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity

Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes

Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes

Impact of hypertension on various markers of subclinical atherosclerosis in early type 2 diabetes

Impact of hypertension on various markers of subclinical atherosclerosis in early type 2 diabetes

Exists a role for serum irisin in Egyptian Behcet’s patients with subclinical atherosclerosis?

Exists a role for serum irisin in Egyptian Behcet’s patients with subclinical atherosclerosis?

Verbundene Objekte